- Filed
- Apr 16, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 1.88B sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $8M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $72M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.42B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.28B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $31.02B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $30.26B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.02B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.82B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $43.2B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $42.76B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.96B sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $247M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $235M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $517M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $1.07B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.45 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.45 |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $880M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $1.34B |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.68B |